3 Reasons Catamaran Is a Buy

Health care is a hot topic right now. U.S. health-care costs are expected to increase to $4.6 trillion by 2020, and President Obama's Affordable Care Act represents the largest overhaul to the industry since Medicare was introduced in 1965. In short, the whole system will be undergoing some significant changes very soon.

Rule Breakers analyst Simon Erickson believes Catamaran (NASDAQ: CTRX  ) is one company well positioned to navigate the turbulent waters. As a pharmacy benefits manager, Catamaran runs its business a little differently from its larger competitors Express Scripts (NASDAQ: ESRX  ) and CVS Caremark (NYSE: CVS  ) .

In the following video, he offers three reasons he thinks the stock is a buy today.

Obamacare will undoubtedly have far-reaching effects. The Motley Fool's new free report "Everything You Need to Know About Obamacare" lets you know how your health insurance, your taxes, and your portfolio could be affected. Click here to read more. 


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2529077, ~/Articles/ArticleHandler.aspx, 4/21/2014 1:16:40 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement